Clinical trial / 2008
Flaxseed supplementation before surgery significantly lowered prostate cancer tumor proliferation rates, while low-fat diet alone did not.
Prostate cancer patients (n = 161) awaiting surgery were randomly assigned to a usual diet control, flaxseed supplementation (30 g/d), a low-fat diet (<20% energy), or a combined flaxseed and low-fat diet for an average of 30 days. Proliferation rates (Ki-67) were significantly lower (P < 0.002) in men in the flaxseed arms, with median Ki-67-positive ratios of 1.66 (flaxseed) and 1.50 (flaxseed + low-fat) compared to 3.23 (control) and 2.56 (low-fat). No significant differences between arms were observed for side effects, apoptosis, or most serologic endpoints, though low-fat diets significantly decreased serum cholesterol (P = 0.048).
- Study type
- Multisite randomized controlled trial
- Who was studied
- 161 prostate cancer patients scheduled for prostatectomy at least 21 days later
- What was measured
- Tumor proliferation (Ki-67), apoptosis, and serologic biomarkers
THE PAPER
Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery.
Demark-Wahnefried W, Polascik TJ, George SL, Switzer BR, Madden JF, Ruffin MT, Snyder DC, Owzar K, Hars V, Albala DM, Walther PJ, Robertson CN, Moul JW, Dunn BK, Brenner D, Minasian L, Stella P, Vollmer RT. Cancer Epidemiol Biomarkers Prev, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.